A citation-based method for searching scientific literature

Informativeness of patient initial reports of adverse drug reactions. Can it be improved by a pharmacovigilance centre?
F Kheloufi, A Default, F Rouby, D Laugier-Castellan, M Boyer, B Rodrigues, J Ponte-Astoul, M J Jean-Pastor, O Blin, J Micallef. Eur J Clin Pharmacol 2017
Times Cited: 6






Login to export Results
Don't have an account? Register here

List of co-cited articles
28 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis.
Leàn Rolfes, Florence van Hunsel, Laura van der Linden, Katja Taxis, Eugène van Puijenbroek. Drug Saf 2017
39
4
66

ADR Reporting by the General Public: Lessons Learnt from the Dutch and Swedish Systems.
Linda Härmark, Florence van Hunsel, Birgitta Grundmark. Drug Saf 2015
42
3
50

The value of patient reporting to the pharmacovigilance system: a systematic review.
Pedro Inácio, Afonso Cavaco, Marja Airaksinen. Br J Clin Pharmacol 2017
96
3
50

Patient Reporting in the EU: Analysis of EudraVigilance Data.
Marin Banovac, Gianmario Candore, Jim Slattery, Francois Houÿez, David Haerry, Georgy Genov, Peter Arlett. Drug Saf 2017
38
3
50

Adverse drug reaction reports of patients and healthcare professionals-differences in reported information.
Leàn Rolfes, Florence van Hunsel, Sarah Wilkes, Kees van Grootheest, Eugène van Puijenbroek. Pharmacoepidemiol Drug Saf 2015
37
3
50

Factors affecting patient reporting of adverse drug reactions: a systematic review.
Rania Al Dweik, Dawn Stacey, Dafna Kohen, Sanni Yaya. Br J Clin Pharmacol 2017
58
3
50

The contribution of direct patient reported ADRs to drug safety signals in the Netherlands from 2010 to 2015.
Florence van Hunsel, Susan de Waal, Linda Härmark. Pharmacoepidemiol Drug Saf 2017
23
3
50

Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre.
Sarah Watson, Rebecca E Chandler, Henric Taavola, Linda Härmark, Birgitta Grundmark, Alem Zekarias, Kristina Star, Florence van Hunsel. Drug Saf 2018
24
3
50

[Adverse drug reactions: a pilot study on patient reporting through patient associations].
Daphney Nasrallah-Irles, Anne Castot, Laure Thomas, Samy Babai, Bernard Delorme, Hervé Le-Louët. Therapie 2008
7
2
33

Analysis of the effect of sentiment analysis on extracting adverse drug reactions from tweets and forum posts.
Ioannis Korkontzelos, Azadeh Nikfarjam, Matthew Shardlow, Abeed Sarker, Sophia Ananiadou, Graciela H Gonzalez. J Biomed Inform 2016
41
2
33

Vigi4Med Scraper: A Framework for Web Forum Structured Data Extraction and Semantic Representation.
Bissan Audeh, Michel Beigbeder, Antoine Zimmermann, Philippe Jaillon, Cédric Bousquet. PLoS One 2017
7
2
33

Evaluating Social Media Networks in Medicines Safety Surveillance: Two Case Studies.
Preciosa M Coloma, Benedikt Becker, Miriam C J M Sturkenboom, Erik M van Mulligen, Jan A Kors. Drug Saf 2015
30
2
33

WHO strategy for collecting safety data in public health programmes: complementing spontaneous reporting systems.
Shanthi N Pal, Chris Duncombe, Dennis Falzon, Sten Olsson. Drug Saf 2013
111
2
33

Pharmacovigilance from social media: mining adverse drug reaction mentions using sequence labeling with word embedding cluster features.
Azadeh Nikfarjam, Abeed Sarker, Karen O'Connor, Rachel Ginn, Graciela Gonzalez. J Am Med Inform Assoc 2015
181
2
33

Quality criteria for early signals of possible adverse drug reactions.
I R Edwards, M Lindquist, B E Wiholm, E Napke. Lancet 1990
73
2
33

Deep learning for pharmacovigilance: recurrent neural network architectures for labeling adverse drug reactions in Twitter posts.
Anne Cocos, Alexander G Fiks, Aaron J Masino. J Am Med Inform Assoc 2017
65
2
33

Investigating patient narratives posted on Internet and their informativeness level for pharmacovigilance purpose: The example of comments about statins.
Farid Kheloufi, Anne Default, Olivier Blin, Joelle Micallef. Therapie 2017
7
2
33

Systematic review on the prevalence, frequency and comparative value of adverse events data in social media.
Su Golder, Gill Norman, Yoon K Loke. Br J Clin Pharmacol 2015
58
2
33

Undesirable effects related to oral antineoplastic drugs: comparison between patients' internet narratives and a national pharmacovigilance database.
Arnaud Pages, Emmanuelle Bondon-Guitton, Jean Louis Montastruc, Haleh Bagheri. Drug Saf 2014
26
2
33

Adverse Drug Reaction Identification and Extraction in Social Media: A Scoping Review.
Jérémy Lardon, Redhouane Abdellaoui, Florelle Bellet, Hadyl Asfari, Julien Souvignet, Nathalie Texier, Marie-Christine Jaulent, Marie-Noëlle Beyens, Anita Burgun, Cédric Bousquet. J Med Internet Res 2015
55
2
33

Filtering big data from social media--Building an early warning system for adverse drug reactions.
Ming Yang, Melody Kiang, Wei Shang. J Biomed Inform 2015
59
2
33

Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.
A Blenkinsopp, P Wilkie, M Wang, P A Routledge. Br J Clin Pharmacol 2007
169
2
33

Key pharmacovigilance stakeholders' experiences of direct patient reporting of adverse drug reactions and their prospects of future development in the European Union.
P Inácio, A Cavaco, E Allan, M Airaksinen. Public Health 2018
6
2
33

Dedicated mobile application for drug adverse reaction reporting by patients with relapsing remitting multiple sclerosis (Vigip-SEP study): study protocol for a randomized controlled trial.
Gilles Defer, Florian Le Caignec, Sophie Fedrizzi, François Montastruc, Damien Chevanne, Jean-Jacques Parienti, Laure Peyro-Saint-Paul. Trials 2018
11
2
33

Experiences with adverse drug reaction reporting by patients: an 11-country survey.
Florence van Hunsel, Linda Härmark, Shanthi Pal, Sten Olsson, Kees van Grootheest. Drug Saf 2012
90
2
33

Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authorities' Views and Needs.
Cristiano Matos, Linda Härmark, Florence van Hunsel. Drug Saf 2016
26
2
33

The Impact of Experiencing Adverse Drug Reactions on the Patient's Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands.
Leàn Rolfes, Florence van Hunsel, Katja Taxis, Eugène van Puijenbroek. Drug Saf 2016
32
2
33

Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
A J Avery, C Anderson, C M Bond, H Fortnum, A Gifford, P C Hannaford, L Hazell, J Krska, A J Lee, D J McLernon,[...]. Health Technol Assess 2011
163
2
33

Causality assessment in pharmacovigilance: The French method and its successive updates.
Ghada Miremont-Salamé, Hélène Théophile, Françoise Haramburu, Bernard Bégaud. Therapie 2016
165
1
16

21st century pharmacovigilance: efforts, roles, and responsibilities.
Peter J Pitts, Hervé Le Louet, Yola Moride, Rena M Conti. Lancet Oncol 2016
31
1
16

First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.
Geneviève Durrieu, Aurore Palmaro, Laure Pourcel, Céline Caillet, Angeline Faucher, Alexis Jacquet, Shéhérazade Ouaret, Marie Christine Perault-Pochat, Carmen Kreft-Jais, Anne Castot,[...]. Drug Saf 2012
20
1
16

vigiGrade: a tool to identify well-documented individual case reports and highlight systematic data quality issues.
Tomas Bergvall, G Niklas Norén, Marie Lindquist. Drug Saf 2014
99
1
16

Mining adverse drug reactions from online healthcare forums using hidden Markov model.
Hariprasad Sampathkumar, Xue-wen Chen, Bo Luo. BMC Med Inform Decis Mak 2014
34
1
16

Adverse drug reaction reporting by patients: an overview of fifty countries.
Florence Margraff, Delphine Bertram. Drug Saf 2014
46
1
16

Combination of Deep Recurrent Neural Networks and Conditional Random Fields for Extracting Adverse Drug Reactions from User Reviews.
Elena Tutubalina, Sergey Nikolenko. J Healthc Eng 2017
14
1
16

Strategies to improve adverse drug reaction reporting: a critical and systematic review.
Cristian Gonzalez-Gonzalez, Elena Lopez-Gonzalez, Maria T Herdeiro, Adolfo Figueiras. Drug Saf 2013
66
1
16

Testing and implementing signal impact analysis in a regulatory setting: results of a pilot study.
Emma Heeley, Patrick Waller, Jane Moseley. Drug Saf 2005
12
1
16

[Comparative relevance of declaration of side effects by patients and health professionals].
Audrey Lagneau, Caroline Vigier, Alexandre Marianna, Rachel Serfaty, Fanny Rocher, Anne Spreux, Milou-Daniel Drici. Therapie 2017
6
1
16

[Causes for the underreporting of adverse drug events by health professionals: a systematic review].
Fabiana Rossi Varallo, Synara de Oliveira Paim Guimarães, Samir Antonio Rodrigues Abjaude, Patricia de Carvalho Mastroianni. Rev Esc Enferm USP 2014
54
1
16

Social media and pharmacovigilance: A review of the opportunities and challenges.
Richard Sloane, Orod Osanlou, David Lewis, Danushka Bollegala, Simon Maskell, Munir Pirmohamed. Br J Clin Pharmacol 2015
58
1
16

Use of the internet as a health information resource among French young adults: results from a nationally representative survey.
François Beck, Jean-Baptiste Richard, Viet Nguyen-Thanh, Ilaria Montagni, Isabelle Parizot, Emilie Renahy. J Med Internet Res 2014
159
1
16

Drug related problems with Antiparkinsonian agents: consumer Internet reports versus published data.
Sabrina Schröder, York Francis Zöllner, Marion Schaefer. Pharmacoepidemiol Drug Saf 2007
25
1
16

The validity and reliability of a signal impact assessment tool.
Leàn Rolfes, Judith Kolfschoten, Florence van Hunsel, Eugène van Puijenbroek. Pharmacoepidemiol Drug Saf 2016
9
1
16

Patient perspectives of dabigatran: analysis of online discussion forums.
Mary S Vaughan Sarrazin, Peter Cram, Alexandur Mazur, Melissa Ward, Heather Schacht Reisinger. Patient 2014
27
1
16

Analysis of patients' narratives posted on social media websites on benfluorex's (Mediator® ) withdrawal in France.
M Abou Taam, C Rossard, L Cantaloube, N Bouscaren, G Roche, L Pochard, F Montastruc, A Herxheimer, J L Montastruc, H Bagheri. J Clin Pharm Ther 2014
25
1
16

Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports.
S J Evans, P C Waller, S Davis. Pharmacoepidemiol Drug Saf 2001
662
1
16

Internet accounts of serious adverse drug reactions: a study of experiences of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Tehreem F Butt, Anthony R Cox, Jan R Oyebode, Robin E Ferner. Drug Saf 2012
31
1
16

Impact analysis of signals detected from spontaneous adverse drug reaction reporting data.
Patrick Waller, Emma Heeley, Jane Moseley. Drug Saf 2005
25
1
16

Exploiting online discussions to discover unrecognized drug side effects.
H Wu, H Fang, S J Stanhope. Methods Inf Med 2013
24
1
16

Utilizing social media data for pharmacovigilance: A review.
Abeed Sarker, Rachel Ginn, Azadeh Nikfarjam, Karen O'Connor, Karen Smith, Swetha Jayaraman, Tejaswi Upadhaya, Graciela Gonzalez. J Biomed Inform 2015
202
1
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.

Longstocking, LLC. © 2021
Home | About Us | FAQs | Terms & Privacy